Podcast on the Management of Adverse Events Associated with Lorlatinib

Here Dr Todd Bauer and Dr Erin Bertino cover some of the unmet needs in patients with anaplastic lymphoma kinase-positive lung cancer, the development of lorlatinib, and how it's being used in clinical practice. They also look at how to manage some of the common adverse events, particularly central nervous system toxicity and hyperlipidemia, that they see a lot in the clinic.

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-022-02050-3. All conflicts of interest can be found online.

This podcast is intended for medical professionals only.

Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.